目的 探究免充气锁骨下入路腔镜甲状腺全切除术（ETGTA）对甲状腺乳头状癌（PTC）患者美容满意度及并发症的影响。方法 选择2022年1月—2024年12月进行诊治的PTC患者80例,其中接受传统开放手术+中央区淋巴结清扫术治疗者纳入对照组（48例）,接受ETGTA+中央区淋巴结清扫术治疗者纳入研究组（32例）。观察两组患者的手术指标、美容满意度和并发症情况。结果 相较于对照组,研究组患者的手术时间更长,术后引流量更多、美容满意度评分更高、颈部不适的发生率更低（均P<0.05）。在喉返神经损伤和甲状旁腺功能减退的发生率方面,两组患者之间差异无统计学意义（P>0.05）。结论 对于PTC患者的治疗,锁骨下入路腔镜甲状腺全切除术疗效显著,安全性高及美容效果好。
Objective To investigate the impact of endoscopic thyroidectomy by gasless trans-subclavian approach （ETGTA） on cosmetic satisfaction and complications in patients with papillary thyroid carcinoma （PTC）. Methods A total of 80 PTC patients diagnosed and treated from January 2022 to December 2024 were selected. Among them,48 patients who underwent traditional open surgery combined with central lymph node dissection were included in the control group, and 32 patients who underwent ETGTA combined with central lymph node dissection were included in the study group. Surgical indicators, cosmetic satisfaction, and complications were observed in both groups. Results Compared with the control group,patients in the study group had longer operative time, greater postoperative drainage volumes, higher cosmetic satisfaction, and a lower incidence of neck discomfort （P<0.05）. No statistically significant differences were observed between the two groups in the incidence of recurrent laryngeal nerve injury and hypoparathyroidism （P>0.05）. Conclusion For PTC patients,ETGTA demonstrates significant efficacy, high safety, and excellent cosmetic outcomes.
[1] Baloch ZW, Asa SL, Barletta JA, et al.Overview of the 2022 WHO classification of thyroid neoplasms[J]. Endocr Pathol,2022,33(1):27-63.
[2] Miranda-Filho A, Lortet-Tieulent J, Bray F, et al.Thyroid cancer incidence trends by histology in 25 countries:a population-based study[J]. Lancet Diabetes Endocrinol,2021,9(4):225-234.
[3] Gordon AJ, Dublin JC, Patel E, et al.American Thyroid Association guidelines and national trends in management of papillary thyroid carcinoma[J]. JAMA Otolaryngol Head Neck Surg,2022,148(12):1156-1163.
[4] 季笑语,邵毅,余恬湉,等.免充气锁骨下入路腔镜甲状腺全切除术治疗甲状腺乳头状癌的单中心回顾性研究[J].腹腔镜外科杂志, 2024, 29(3):167-173.
[5] 袁倩,徐燕婷,李逸林,等. 无充气经锁骨下入路腔镜手术治疗甲状腺乳头状癌的疗效观察[J]. 中华内分泌外科杂志,2024,18(4):479-483.
[6] 中国医师协会外科医师分会甲状腺外科医师委员会. 甲状腺手术中甲状旁腺保护专家共识[J]. 中国实用外科杂志,2015,35(7):731-736.
[7] 田文,阳泽龙.甲状腺乳头状癌流行病学及诊疗焦点探讨[J].西安交通大学学报(医学版), 2024, 45(1):44-48.
[8] Zhang X, Hu XJ, Hua KJ.Endoscopic hemithyroidectomy plus prophylactic central neck dissection via breast approach versus gasless transaxillary approach in treating low-risk papillary thyroid cancer: a retrospective series[J]. Updates Surg, 2023,75(3):707-715.
[9] 季笑语,邵毅,余恬湉,等. 免充气锁骨下入路腔镜甲状腺全切除术治疗甲状腺乳头状癌的单中心回顾性研究[J]. 腹腔镜外科杂志,2024,29(3):167-173.
[10] Neary PM, O'Connor OJ, Shafiq A,et al. The impact of routine open nonsuction drainage on fluid accumulation after thyroid surgery: a prospective randomised clinical trial[J]. World J Surg Oncol,2012,10:72.
[11] 曲衍清,苗成,张晓健,等.经锁骨下入路腔镜手术与开放手术治疗甲状腺良性肿瘤对比[J].中华生物医学工程杂志, 2025, 31(1):52-56.
[12] Kang YJ, Stybayeva G, Hwang SH.Surgical completeness and safety of minimally invasive thyroidectomy in patients with thyroid cancer:a network meta-analysis[J]. Surgery,2023,173(6):1381-1390.
[13] 张洁,许文静,王莎莎. 免充气经锁骨下入路腔镜手术对cN0期单侧甲状腺乳头状癌患者颈部功能、应激反应的影响[J]. 四川生理科学杂志,2024,46(11):2376-2378.
[14] 费阳,李阳,陈峰,等. 完全腔镜甲状腺癌根治术对患者创伤应激与免疫的影响[J]. 腹腔镜外科杂志,2022,27(7):483-486.
[15] Sawka AM, Ghai S, Rotstein L, et al.Decision regret following the choice of surgery or active surveillance for small,low-risk papillary thyroid cancer:a prospective cohort study[J]. Thyroid,2024,34(5):626-634.
